Mercer Global Advisors’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.8M | Sell |
133,767
-36,134
| -21% | -$7.51M | 0.04% | 256 |
|
|
2026
Q1 | $35.9M | Buy |
169,901
+6,038
| +4% | +$1.3M | 0.05% | 220 |
|
|
2025
Q4 | $33.6M | Sell |
163,863
-4,594
| -3% | -$865K | 0.05% | 229 |
|
|
2025
Q3 | $26.4M | Buy |
168,457
+10,826
| +7% | +$1.67M | 0.04% | 245 |
|
|
2025
Q2 | $26.5M | Buy |
157,631
+49,538
| +46% | +$7.35M | 0.05% | 191 |
|
|
2025
Q1 | $14.9M | Buy |
108,093
+69,318
| +179% | +$8.84M | 0.03% | 280 |
|
|
2024
Q4 | $4.59M | Sell |
38,775
-691
| -2% | -$80.7K | 0.01% | 564 |
|
|
2024
Q3 | $4.35M | Buy |
39,466
+13,388
| +51% | +$1.4M | 0.01% | 535 |
|
|
2024
Q2 | $2.56M | Buy |
26,078
+1,761
| +7% | +$179K | 0.01% | 653 |
|
|
2024
Q1 | $2.72M | Buy |
24,317
+2,725
| +13% | +$294K | 0.01% | 638 |
|
|
2023
Q4 | $2.18M | Buy |
21,592
+1,625
| +8% | +$161K | 0.01% | 714 |
|
|
2023
Q3 | $1.73M | Buy |
19,967
+357
| +2% | +$32.3K | 0.01% | 754 |
|
|
2023
Q2 | $1.85M | Buy |
19,610
+196
| +1% | +$16.6K | 0.01% | 747 |
|
|
2023
Q1 | $1.47M | Sell |
19,414
-3,456
| -15% | -$261K | 0.01% | 778 |
|
|
2022
Q4 | $1.76M | Sell |
22,870
-3,607
| -14% | -$274K | 0.01% | 704 |
|
|
2022
Q3 | $1.76M | Sell |
26,477
-1,862
| -7% | -$118K | 0.01% | 658 |
|
|
2022
Q2 | $1.48M | Buy |
28,339
+115
| +0.4% | +$6.54K | 0.01% | 690 |
|
|
2022
Q1 | $1.6M | Buy |
28,224
+5,643
| +25% | +$302K | 0.01% | 714 |
|
|
2021
Q4 | $1.16M | Buy |
22,581
+152
| +0.7% | +$7.46K | 0.01% | 818 |
|
|
2021
Q3 | $1.11M | Sell |
22,429
-266
| -1% | -$14.4K | 0.01% | 814 |
|
|
2021
Q2 | $1.3M | Buy |
22,695
+2,322
| +11% | +$136K | 0.01% | 732 |
|
|
2021
Q1 | $1.24M | Sell |
20,373
-945
| -4% | -$52.2K | 0.01% | 703 |
|
|
2020
Q4 | $1.14M | Sell |
21,318
-1,168
| -5% | -$60.6K | 0.01% | 569 |
|
|
2020
Q3 | $1.06M | Buy |
22,486
+4,015
| +22% | +$206K | 0.02% | 538 |
|
|
2020
Q2 | $964K | Buy |
18,471
+4
| +0% | +$206 | 0.02% | 489 |
|
|
2020
Q1 | $885K | Sell |
18,467
-667
| -3% | -$34.6K | 0.02% | 506 |
|
|
2019
Q4 | $968K | Sell |
19,134
-1,728
| -8% | -$89.3K | 0.02% | 536 |
|
|
2019
Q3 | $984K | Buy |
20,862
+980
| +5% | +$44.7K | 0.02% | 489 |
|
|
2019
Q2 | $936K | Buy |
19,882
+1,277
| +7% | +$58.9K | 0.02% | 478 |
|
|
2019
Q1 | $896K | Buy |
+18,605
| New | +$932K | 0.03% | 442 |
|
Other funds holding CAH
Mercer Global Advisors's CAH Position: Q2 2026 in Review
Mercer Global Advisors reduced its Cardinal Health (CAH) stake by 21% in Q2 2026, selling an estimated $7.51M and leaving 133,767 shares worth $31.8M. The position accounts for 0.04% of the portfolio, ranked #256.
Mercer Global Advisors first reported a position in CAH in Q1 2019 and has held it in 30 quarters since. The position peaked at $35.9M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Mercer Global Advisors held 133,767 shares of Cardinal Health worth $31.8M as of Q2 2026.
- Mercer Global Advisors sold 36,134 Cardinal Health shares in Q2 2026, an estimated $7.51M.
- Cardinal Health made up 0.04% of Mercer Global Advisors's portfolio in Q2 2026, its #256 holding.
- Mercer Global Advisors first reported a position in Cardinal Health in Q1 2019 and has held it in 30 quarters since.
- Mercer Global Advisors's Cardinal Health position peaked at $35.9M in Q1 2026.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.